Pages

Thursday, 18 October 2018

Novartis boosts outlook, announces $2.1B Endocyte deal


Novartis boosts outlook, announces $2.1B Endocyte deal



The Swiss healthcare company is paying 24 dollars per share in cash for Endocyte.

Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)